GenomeQuest Appoints Anthony Flynn as CMO

Share Article

Ex-CMO from $450M High-Growth Technology Company to Lead Launch into Whole-Genome Analysis and Personalized Medicine

Anthony Flynn, GenomeQuest Chief Marketing Officer

...together with pharma, the NIH, hospitals, and many others, we are committed to cracking the 'information bottleneck' around whole-genome sequencing.

GenomeQuest, the global leader in sequence data management, today announced the appointment of Anthony Flynn to the position of chief marketing officer (CMO).

Flynn comes to the company with a 20-year history of helping shape and develop new markets in high technology. His assignments include CMO at Bentley Systems, Inc., a provider of engineering software to the global infrastructure market, which grew from $27M to $450M during his span with the company. Flynn also served in marketing management for two start-ups in electronic design automation (EDA) that each achieved IPO and market leadership.

GenomeQuest CEO, Ron Ranauro, comments, "We're thrilled to have Tony on the GenomeQuest team. He has a unique ability to understand and communicate value to technical buyers as well as management. He also has an inherent sense of how new software best evolves and develops in organizations and across industries."

Flynn notes, "I am likewise thrilled to join GenomeQuest. It's a wonderful opportunity to apply my skills and add value to an industry and company that is doing great things and on the verge of major breakthroughs. Specifically, together with pharma, the NIH, hospitals, and many others, we are committed to cracking the 'information bottleneck' around whole-genome sequencing. As a result, I think that we'll soon see a stream of fundamental improvements in health care through the delivery of highly-anticipated 'personalized medicine.'"

Flynn's immediate marketing plans for the company include an upcoming campaign on the company's ability to provide whole-and multi-genome analysis (WGA) -- a critical market requirement for personalized medicine now broadly enabled by the GenomeQuest sequence database engine. Started by company CSO Dr. Jean-Jacques Codani to support the Human Genome Project, the GQ Engine offers high-performance, "embarrassingly parallel" comparison and management of genomic sequence databases.

About GenomeQuest
GenomeQuest provides sequence data management to life science organizations. Pharmaceutical firms, biotech companies, core labs, hospitals, clinics, and their researchers can store, analyze, share, and manage their increasing volume of genome sequence, annotation, and variation data with GenomeQuest products. Globally, 17 of the top 20 pharmaceuticals use GenomeQuest for mission critical work.

© 2010 GenomeQuest Inc. All rights reserved. GenomeQuest is a servicemark and the GQ Engine is a trademark of GenomeQuest Inc.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dana Wormer
Visit website